论文部分内容阅读
目的 观察国产来立信（乳酸左氧氟沙星） 治疗尿路感染的疗效及安全性。方法 将６０ 例患者随机分成两组，治疗组（３０ 例）静滴来立信，对照组３０ 例静滴妥布霉素，比较两组的有效率及不良反应发生率。结果 治疗组临床有效率、细菌阴转率、不良反应发生率分别为９６．７％ 、８３．３％ 、３．３％ ， 对照组分别为８０．０％ 、６０．０％ 、２０．０％ ， 两组比较有显著性差异。结论 来立信治疗尿路感染， 近期疗效好， 不良反应少
Objective To observe the efficacy and safety of domestic Lixin (levofloxacin lactate) in the treatment of urinary tract infection. Methods Sixty patients were randomly divided into two groups. The treatment group (30 patients) received intravenous infusion of Ericsson, and the control group, 30 patients received intravenous tobramycin. The effective rate and incidence of adverse reactions in the two groups were compared. Results The clinical effective rate, bacterial negative conversion rate and adverse reaction rate in the treatment group were 96.7%, 83.3% and 3.3% respectively, while those in the control group were 80.0%, 60.0% and 20.0 %, There are significant differences between the two groups. Conclusion Ericsson treatment of urinary tract infection, the recent good effect, fewer adverse reactions